Allergy Drugs News

Drugs

> Allergy Drugs

FORMATS: RSS | EMAIL | MOBILE

Latest Allergy Drugs News

Hospital warns of perils of condition for young children 8 Aug 2008 17:59 GMT
... easily mistaken for other afflictions, such as allergic reactions. The hospital cited a recent case ... recent case of a 3-year-old girl, who developed burn-like blisters and peeling skin after contracting ... for other skin diseases, which may delay treatment and lead to worsening of symptoms, she ...
OTCPicks.com Daily Market Movers Digest Midday Report for Friday, August 8th QMCI, QLTY, MIVA, ISTA 8 Aug 2008 17:56 GMT
... of therapies for inflammation, ocular pain, glaucoma, allergy, dry eye, vitreous hemorrhage, and diabetic retinopathy in ... second Phase III clinical trial product for allergic conjunctivitis; Bepotastine nasal for the treatment of ... ISTA Pharmaceuticals sells its products primarily to drug wholesalers, retailers, and distributors, including chain drug ...
Buying Healthcare Stocks for an Obama Presidency (Part III) 8 Aug 2008 17:27 GMT
... In a previous post, I spelled out . In that ... the development and management of two cholesterol-lowering drugs and an allergy/asthma drug. Political concerns over government price negotiations with ...
Letters - NPfIT is improving GPs' lives in so many ways 8 Aug 2008 16:56 GMT
... Letters - NPfIT is improving GPs' lives in ... clinicians to access patient information about their medication and allergies and will with the patients consent provide ...
XOMA Reports Second Quarter 2008 Financial Results 8 Aug 2008 14:12 GMT
... BERKELEY, Calif., Aug 7, 2008 (PrimeNewswire via COMTEX ... work activities with the National Institute of Allergy and Infectious Disease (NIAID) and Aveo Pharmaceuticals, Inc. ... tolerated and without any evidence of serious drug-related adverse events or infusion reactions. Clearance of ...

Increased research costs and lower revenue lead to larger 2nd - quarter loss for Xoma 8 Aug 2008 13:55 GMT
... Xoma reported $5.6 million in contract revenue, down from ... Corp. and the U.S. National Institute of Allergy and Infectious Diseases. Royalty revenue improved to $5.3 ... Xoma licensed to Genentech Inc.: the psoriasis drug Raptiva, and macular degeneration treatment Lucentis. Research ...
Xoma 2Q loss grows on expenses, lower revenue 8 Aug 2008 13:55 GMT
... Xoma 2Q loss grows on expenses, lower revenue BERKELEY, Calif. ... more money to develop a pair of drug candidates. On average, analysts had expected a ... Corp. and the U.S. National Institute of Allergy and Infectious Diseases. Royalty revenue improved to $5.3 ...
Pharmaceutical Industry Addresses Drug Contamination on a Microscopic Level 8 Aug 2008 13:54 GMT
... and General News > Pharmaceutical Industry Addresses Drug Contamination on a Microscopic Level ( Nanowerk ... the production floor. Because counterfeit or contaminated drugs can result in allergic reactions or even death (as evidenced by the ...
Shekar Nethralaya Introduces A New Permanent Eye Treatment For Keratoconus 8 Aug 2008 13:13 GMT
... Shekar Nethralaya Introduces A New Permanent Eye Treatment For Keratoconus Karnataka : Shekar Nethralaya, Bangalore ... noted has been eye rubbing, itching and allergic eye diseases. As because we don�t know ... advances two newer treatment modalities have been developed. One is to strengthen the weekend cornea ...
Henna hazard: Chemical causes ornate allergies 8 Aug 2008 13:10 GMT
... black henna tattoos can cause a severe allergic reaction, causing the skin to redden, swell ... cases, that’s much, much longer. “These skin allergies themselves are not dangerous,” says Dr. Colby ... cause permanent sensitivity to PPD, and that allergy can cross-react with chemical relatives in certain ...
Protect your family against West Nile 8 Aug 2008 12:38 GMT
... check the product label. If a child develops a rash or other apparent allergic reaction from an insect repellent, stop using ... for Los Angeles County. There is no treatment for West Nile Virus, and the risk ...
ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 8 Aug 2008 12:36 GMT
... "Xibrom sales continued to grow strongly during the second ... filing for Xibrom 0.09% as a once-daily treatment for pain and inflammation associated with cataract ... include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets ...
GenVec Reports Second Quarter 2008 Financial Results 8 Aug 2008 12:36 GMT
... GenVec reported a net loss of $6.6 million ($0.08 ... (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National ... is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product candidate, TNFerade(TM), ...
Indian-origin researcher uncovers mechanism behind allergies 8 Aug 2008 11:57 GMT
... identification of the molecular mechanisms that underpin allergic reactions. Dr. Inder Verma, a professor in ... responses. "These results may allow us to develop acute inhibitors of allergic reactions that do ... do not have the side-effects of current treatments such as drowsiness," he says. He says ...
Abbott study shows investigational heat-stable Norvi... 8 Aug 2008 11:19 GMT
... current soft-gelatin capsule provide similar levels of drug in the blood. The heat-stable Norvir tablet ... in patients who have had a serious allergic reaction to NORVIR or any of its ingredients. ... of its ingredients. Taking KALETRA with certain drugs can cause serious problems or death.� KALETRA ...

1 - 15 / 414 NEXT >>>

NOT SATISFIED WITH THIS ALLERGY DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.

These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>